ProANP plasma measurement predicts all-cause mortality in acutely hospitalised patients: a cohort study.

ABSTRACT:

Importance

The association of natriuretic peptide measurement with all-cause mortality in a broad selection of acutely admitted patients has not yet been examined.

Objective

To test the risk association between pro-atrial natriuretic peptide (ANP) and short-term and long-term mortality and its predictive value in acutely hospitalised patients and compare this to N-terminal B-type natriuretic peptide (NT-proBNP).

Design, setting and patients

Participants were selected from the Copenhagen Hospital Heart Failure Study (n=3644). Medical history, satisfactory echocardiography and blood samples were available on 2193 participants in 1998-1999 where NT-proBNP was measured. Vital status after discharge was obtained from national central data registers. A total of 1337 partici

SUBMITTER: Lauridsen BK 

PROVIDER: S-EPMC3845039 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature